AU1600897A - Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system - Google Patents

Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system

Info

Publication number
AU1600897A
AU1600897A AU16008/97A AU1600897A AU1600897A AU 1600897 A AU1600897 A AU 1600897A AU 16008/97 A AU16008/97 A AU 16008/97A AU 1600897 A AU1600897 A AU 1600897A AU 1600897 A AU1600897 A AU 1600897A
Authority
AU
Australia
Prior art keywords
individualised
optimising
selection
immune system
therapeutic plan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16008/97A
Inventor
Efim Benenson
Reinhard Pelzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1600897A publication Critical patent/AU1600897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16008/97A 1996-02-06 1997-02-05 Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system Abandoned AU1600897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96101649 1996-02-06
EP96101649 1996-02-06
PCT/EP1997/000509 WO1997029370A1 (en) 1996-02-06 1997-02-05 Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system

Publications (1)

Publication Number Publication Date
AU1600897A true AU1600897A (en) 1997-08-28

Family

ID=8222466

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16008/97A Abandoned AU1600897A (en) 1996-02-06 1997-02-05 Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system

Country Status (2)

Country Link
AU (1) AU1600897A (en)
WO (1) WO1997029370A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1740003A1 (en) * 1989-05-24 1992-06-15 Киевский Медицинский Институт Им.Акад.А.А.Богомольца Method for treating the cases of rheumatoid arthritis
AU4796393A (en) * 1992-07-31 1994-03-03 Immulogic Pharmaceutical Corporation Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen
EP0688223A4 (en) * 1993-03-12 1998-05-13 Cellcor Inc -i(IN VITRO) ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS
WO1995014081A1 (en) * 1993-11-19 1995-05-26 The Scripps Research Institute Method for detection of inflammatory agents

Also Published As

Publication number Publication date
WO1997029370A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
AU2003204907A1 (en) A System for Treating Skin Disorders
AU1142197A (en) Apparatus and methods for ultrasonically enhanced intraluminal therapy
GB9624256D0 (en) Watere treatment process and system
AU4975996A (en) Method and device for administering analgesics
EP0759306A3 (en) Medicine administering apparatus
EP0595783A3 (en) Ultrasonic treatment system
HK1009543A1 (en) Interactive wagering system and process
AU4069393A (en) Process and device for placing a patient in the correct position for treatment
IL119673A0 (en) Advanced nuclear medicine system
AU2816589A (en) Self-regulated therapeutic agent delivery system and method
AU4776096A (en) Whey treatment process
IL118051A (en) Capsule preparations for plant treatment
AU7366791A (en) A method and a pharmaceutical preparation for treating pain
HUP9801130A3 (en) Transdermal therapeutic system for administering testosterone
AU4592793A (en) Device for use in light-beam treatment
AU7430396A (en) Steaming device for skin treatment
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
GB9515868D0 (en) Therapeutic method
AU670864B2 (en) Magnetic therapeutic apparatus
AU1600897A (en) Process for optimising the selection of a basic medicament in an individualised therapeutic plan for treating disturbances of the immune system
AU6387994A (en) Device for medical treatment
AU2424392A (en) Method for inhibiting blood coagulant activity
HUP9801884A3 (en) Methods for maintaining sterility in plants
AU5010196A (en) Therapeutic benzoxazoles
AU3142589A (en) Supervising system for distribution lines